Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2003
12/04/2003WO2003100021A2 Methods and dna constructs for high yield production of polypeptides
12/04/2003WO2003100020A2 Methods and constructs for high yield expression of clostripain
12/04/2003WO2003100016A2 Protein modification and maintenance molecules
12/04/2003WO2003100015A2 Polypeptide cleavage process
12/04/2003WO2003100007A2 Eta-1 gene and methods for use
12/04/2003WO2003100004A2 A novel g protein-coupled receptor, gave2
12/04/2003WO2003100003A2 Isolated polynucleotides and methods of promoting a morphology in a fungus
12/04/2003WO2003100001A2 Claudin polypeptides, polynucleotides, and methods of making and use thereof
12/04/2003WO2003100000A2 Amplification and overexpression of oncogenes
12/04/2003WO2003099997A2 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003WO2003099996A2 Detection of secreted polypeptides
12/04/2003WO2003099995A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
12/04/2003WO2003099993A2 Dna sequence confering early and increased secondary metabolite production in streptomyces and method of use
12/04/2003WO2003099992A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003WO2003099991A2 Glp-1 gene delivery for the treatment of type 2 diabetes
12/04/2003WO2003099989A2 Compositions and methods relating to breast specific genes and proteins
12/04/2003WO2003099867A1 Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 1 (avpr1)
12/04/2003WO2003099866A1 Transformed fungi for production of recombinant proteins
12/04/2003WO2003099865A1 Cation channel proteins
12/04/2003WO2003099864A1 Use of monocarboxylate transporter protein for thyroid hormone transport
12/04/2003WO2003099863A2 Resistin binding proteins, their preparation and use
12/04/2003WO2003099862A1 Export and modification of (poly)peptides in the lantibiotic way
12/04/2003WO2003099861A1 Use of a pestivirus ns3-like protein for inducing cell apoptosis
12/04/2003WO2003099860A2 Immunogenic composition and peptide sequences for prevention and treatment of an hsv condition
12/04/2003WO2003099859A2 Novel use of adenoviruses and nucleic acids coding therefor
12/04/2003WO2003099856A1 Method of artificially synthesizing proteoglycan
12/04/2003WO2003099854A2 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
12/04/2003WO2003099853A2 Petide amidation process
12/04/2003WO2003099850A2 Mutant p53 (δ126-132) protein and uses thereof
12/04/2003WO2003099848A2 Method for universal enzymatic production of bioactive peptides
12/04/2003WO2003099847A2 Method for enzymatic production of glp-1 (7-36) amide peptides
12/04/2003WO2003099845A2 Fas peptide mimetics and uses thereof
12/04/2003WO2003099843A2 Peptide derivatives, and their use for the synthesis of silicon-based composite materials
12/04/2003WO2003099839A1 Modulators and inhibitors of fibroblast growth factor receptor 5_polypeptides and gene expression thereof.
12/04/2003WO2003099830A2 Cardiolipin compositions, methods of preparation and use
12/04/2003WO2003099779A2 Hemipteran muscarinic receptor
12/04/2003WO2003099778A2 Inhibitors of proteins from the rho-gef family
12/04/2003WO2003099708A1 Process for producing nanoparticle and nanoparticle produced by the process
12/04/2003WO2003099465A1 Synthesis of inorganic structures using templation and catalysis by self assembled repeat protein polymers
12/04/2003WO2003099341A1 Increased delivery of a nucleic acid constrtuct in vivo by the poly-l-glutamate (plg) system
12/04/2003WO2003099340A1 Novel chimeric cd154
12/04/2003WO2003099331A1 Insulin resistance improving agents
12/04/2003WO2003099322A2 Il-11 derivatives and therapeutic uses thereof
12/04/2003WO2003099321A1 Methods for preventing, treating or delaying cardiac toxicity using neuregulin
12/04/2003WO2003099320A1 Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
12/04/2003WO2003099317A1 Novel uses of cephaibols
12/04/2003WO2003099314A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003WO2003099300A1 Neuregulin based methods and compositions for treating cardiovascular diseases
12/04/2003WO2003099201A2 Compositions and methods of use for a fibroblast growth factor
12/04/2003WO2003099193A2 Vaccines
12/04/2003WO2003099003A1 Adiponectin-knoucout nonhuman animal
12/04/2003WO2003098991A2 Employment of rotavirus proteins, derived proteins and peptides for the modulation of tissue permeability
12/04/2003WO2003087356A3 Helicokinin-receptor from insects
12/04/2003WO2003087305A3 Methods and compositions for anchoring stem cells in a microenvironment
12/04/2003WO2003083041A3 Cripto-specific antibodies
12/04/2003WO2003080841A8 Calcineurin activators
12/04/2003WO2003076936A9 Method of preparing a protein array based on biochemical protein-protein interaction
12/04/2003WO2003070981A3 Seequences specifically deleted mycobacterium tuberculosis genome and their use in diagnostics and as vaccines
12/04/2003WO2003066810A3 Recombinant bovine immunodeficiency virus based gene transfer system
12/04/2003WO2003065928A3 Therapeutic polyesters and polyamides
12/04/2003WO2003064591A3 Abca8 nucleic acids and proteins, and uses thereof
12/04/2003WO2003063899A3 Vaccine adjuvant based on a cd4 0 ligand
12/04/2003WO2003063679A3 Hepatitis e virus clones and methods of their use
12/04/2003WO2003062386A3 Syndecans and angiogenesis
12/04/2003WO2003060096A3 Assay for the detection of factors that modulate the expression of ingap
12/04/2003WO2003059379A3 Immunogenic carcinoembryonic antigen (cea)
12/04/2003WO2003059290A3 Diagnostic and therapeutic uses of topors
12/04/2003WO2003057852A3 Purification and characterization of hla proteins
12/04/2003WO2003057820A3 Peptide activators of vegf
12/04/2003WO2003057712A3 Humanized lactoferrin and uses thereof
12/04/2003WO2003057168A3 Cancer-associated epitope
12/04/2003WO2003056297A3 Self-assembling polymers, and materials fabricated therefrom
12/04/2003WO2003055439A3 Her2/neu target antigen and use of same to stimulate an immune response
12/04/2003WO2003054158A3 Rapidly maturing fluorescent proteins and methods for using the same
12/04/2003WO2003054017A3 Mono-and dual chemokine/cytokine constructs
12/04/2003WO2003054011A3 Polymorphisms of the octn1 and octn2 cation transporters associated with inflammatory bowel disease
12/04/2003WO2003053351A3 A NOVEL REGULATORY ELEMENT WITHIN THE IL-Iα PROMOTER AND USES THEREOF
12/04/2003WO2003050540A3 Flexible method and apparatus for high throughput production and purification of multiple proteins
12/04/2003WO2003050281A3 Fragments of the human zn-alpha2-glycolprotein and their use in methods of treatment of obesity
12/04/2003WO2003048188A3 15603, a human ion channel family member
12/04/2003WO2003046552A3 Screening method for compounds that modulate neuronal activity
12/04/2003WO2003046134A3 Expression of polypeptides in rod outer segment membranes
12/04/2003WO2003045987A3 A food grade lantibiotic from streptococcus macedonicus and uses thereof
12/04/2003WO2003045980A3 Glycopeptide remodeling using amidases
12/04/2003WO2003040326A3 Methods and materials relating to prokineticin-like polypeptides and polynucleotides
12/04/2003WO2003035892A9 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods
12/04/2003WO2003035677A3 Antimicrobial peptides from the venom of the spider cupiennius salei
12/04/2003WO2003035010A3 Thymosin augmentation of genetic immunization
12/04/2003WO2003034990A3 Angiopoietins and methods of use thereof
12/04/2003WO2003033723A3 Vectors for expressing multiple transgenes
12/04/2003WO2003031462A3 Nogo receptor-mediated blockade of axonal growth
12/04/2003WO2003028537A3 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
12/04/2003WO2003028001A3 Method and pharmaceutical composition for inducing cancer cell-specific apoptosis by combination with tnf family proteins and flavopiridol
12/04/2003WO2003026404A3 Ccr6 chemokine receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003026398A3 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
12/04/2003WO2003025579A3 Use of heart fatty acid binding protein
12/04/2003WO2003025003A3 Hiv-gag codon-optimised dna vaccines
12/04/2003WO2003025002A3 Method and compositions of defensin-antigen fusion proteins and chemokine-antigen fusion proteins as vaccines for tumors and viral infection
12/04/2003WO2003022879A3 Peptides mimicking a cryptic epitope of gp41 hiv-1 and antibodies directed against them
12/04/2003WO2003021273A3 Diagnosis of carcinomas
1 ... 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 ... 2916